Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

CLIK-148

Catalog No. T213525 Copy Product Info
🥰Excellent
CLIK-148 is an oral, highly selective, irreversible inhibitor of cysteine protease that primarily targets cathepsin L. It effectively impedes the cathepsin L-dependent degradation of HMG-CoA reductase on the endoplasmic reticulum (ER) membrane. Additionally, CLIK-148 inhibits the cathepsin L-mediated processing of procholecystokinin (proCCK), leading to reduced production of CCK8. By obstructing cathepsin L degradation of type I collagen secreted by osteoclasts, CLIK-148 decreases tumor-induced bone metastasis and malignant hypercalcemia. This compound is valuable for research into bone metabolism disorders and neuropeptide processing regulation.

CLIK-148

Copy Product Info
🥰Excellent
Catalog No. T213525

CLIK-148 is an oral, highly selective, irreversible inhibitor of cysteine protease that primarily targets cathepsin L. It effectively impedes the cathepsin L-dependent degradation of HMG-CoA reductase on the endoplasmic reticulum (ER) membrane. Additionally, CLIK-148 inhibits the cathepsin L-mediated processing of procholecystokinin (proCCK), leading to reduced production of CCK8. By obstructing cathepsin L degradation of type I collagen secreted by osteoclasts, CLIK-148 decreases tumor-induced bone metastasis and malignant hypercalcemia. This compound is valuable for research into bone metabolism disorders and neuropeptide processing regulation.

CLIK-148
Cas No. 215098-90-1
Pack SizePriceUSA StockGlobal StockQuantity
10 mgInquiry10-14 weeks10-14 weeks
50 mgInquiry10-14 weeks10-14 weeks
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
CLIK-148 is an oral, highly selective, irreversible inhibitor of cysteine protease that primarily targets cathepsin L. It effectively impedes the cathepsin L-dependent degradation of HMG-CoA reductase on the endoplasmic reticulum (ER) membrane. Additionally, CLIK-148 inhibits the cathepsin L-mediated processing of procholecystokinin (proCCK), leading to reduced production of CCK8. By obstructing cathepsin L degradation of type I collagen secreted by osteoclasts, CLIK-148 decreases tumor-induced bone metastasis and malignant hypercalcemia. This compound is valuable for research into bone metabolism disorders and neuropeptide processing regulation.
In vitro
CLIK-148 at 100 nM to 10 μM concentration in rat liver effectively and specifically inhibits tissue Cathepsin L activity at 100 nM, shows almost no inhibition of Cathepsin B and C at 1 μM, and only weakly inhibits Cathepsin S and K at 10 μM. Additionally, CLIK-148 at 50 μM for 24 hours inhibits tissue Cathepsin L activity, blocking the conversion of proCCK to CCK9, and consequently reduces CCK8 production in pituitary AtT-20 cells. CLIK-148 at 1-10 nM for 72 hours efficiently prevents TNF-α-activated osteoclast-mediated bone collagen degradation in both human and mouse cells. Moreover, at 100 μM, CLIK-148 effectively protects HMG-CoA reductase from pathological degradation in C100 cells under necrotic damage conditions.
In vivo
CLIK-148, when administered intraperitoneally at doses of 1-10 mg/kg as a single treatment, significantly inhibits cathepsin L activity in mouse liver, without affecting cathepsin B activity. At 50 mg/kg orally, administered once daily for 7 days, it effectively prevents and treats tumor-induced malignant hypercalcemia in mice. Additionally, doses of 32-128 mg/kg administered orally or intravenously once daily for 7 days effectively suppress direct bone metastasis and local bone destruction by colon cancer cells. Furthermore, doses of 100-200 mg/kg taken orally once daily for 14 days specifically inhibit the process of cancer cell metastasis to bones via the bloodstream in mice.
Chemical Properties
Molecular Weight410.47
FormulaC22H26N4O4
Cas No.215098-90-1
SmilesC(N[C@@H](CC1=CC=CC=C1)C(N(C)C)=O)(=O)[C@@H]2[C@@H](C(NCCC3=CC=CC=N3)=O)O2
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy CLIK-148 | purchase CLIK-148 | CLIK-148 cost | order CLIK-148 | CLIK-148 in vivo | CLIK-148 in vitro | CLIK-148 formula | CLIK-148 molecular weight